Enovis Corporation (ENOV)
44.80
-0.55 (-1.21%)
At close: Jan 14, 2025, 3:59 PM
46.98
4.85%
After-hours Jan 14, 2025, 07:37 PM EST
undefined% (undefined)
| Bid | 40.17 |
| Market Cap | 2.50B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.21 |
| PE Ratio (ttm) | -20.27 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 71.6 |
| Volume | 961,231 |
| Avg. Volume (20D) | 834,472 |
| Open | 45.37 |
| Previous Close | 45.35 |
| Day's Range | 44.16 - 45.79 |
| 52-Week Range | 38.27 - 65.03 |
| Beta | undefined |
About ENOV
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic ev...
Industry Industrial - Machinery
Sector Industrials
IPO Date May 8, 2008
Employees 6,550
Stock Exchange NYSE
Ticker Symbol ENOV
Website https://www.enovis.com
Analyst Forecast
According to 8 analyst ratings, the average rating for ENOV stock is "Buy." The 12-month stock price forecast is $68.5, which is an increase of 52.88% from the latest price.
Buy 75.00%
Hold 12.50%
Sell 0.00%
Next Earnings Release
Enovis Corporation is scheduled to release its earnings on Feb 20, 2025,
before market opens.
Analysts project revenue of $554.57M, reflecting a 21.88% YoY growth and earnings per share of 0.91, making a 15.19% increase YoY.
Analysts project revenue of $554.57M, reflecting a 21.88% YoY growth and earnings per share of 0.91, making a 15.19% increase YoY.
8 months ago ·
Source
-5.9%
Enovis shares are trading lower. The company repor...
Unlock content with
Pro Subscription
